A victory with the potential to change investor perception and alter clinical practice could come from Bavarian Nordic's Prostvac for prostate cancer, which NCI's Schlom cited as one of the most promising in the field.
Hvis Prostvac køre igennem,så er "The Sky is the limit"
Link:Reuter
Hvis Prostvac køre igennem,så er "The Sky is the limit"
Link:Reuter
